Platelet-Rich Fibrin Shows No Benefit for Radiation Patients After Tooth Extraction
Study finds advanced platelet-rich fibrin doesn't improve healing or prevent complications in head and neck cancer survivors.
Summary
Researchers tested whether advanced platelet-rich fibrin (A-PRF) could improve healing and prevent osteoradionecrosis after tooth extraction in head and neck cancer survivors who had received radiation therapy. The randomized controlled trial followed 30 patients with 134 tooth extractions for 120 days, comparing A-PRF treatment to standard care. Results showed no significant differences in pain, healing, or complications between groups, with no cases of osteoradionecrosis occurring in either group. The study concludes that A-PRF provides no additional benefits for post-extraction healing in this high-risk population.
Detailed Summary
Head and neck cancer survivors face increased risks of serious complications after dental procedures due to radiation damage to jaw tissues. Osteoradionecrosis (ORN), a severe condition where irradiated bone tissue dies, is one of the most feared complications following tooth extraction in these patients.
Researchers conducted a randomized controlled trial to test whether advanced platelet-rich fibrin (A-PRF) could improve healing outcomes. The study included 30 patients who had previously received head and neck radiation therapy and required tooth extractions. A total of 134 extraction sites were randomly assigned to receive either A-PRF treatment or standard clot maintenance.
Patients were monitored for 120 days, with assessments at 7, 14, 30, 60, 90, and 120 days post-surgery. Researchers evaluated pain levels using visual analog scales and monitored for healing progress and complications including ORN, edema, bleeding, and infection.
Surprisingly, the results showed no statistically significant differences between the A-PRF and control groups across all measured parameters. No cases of osteoradionecrosis occurred in either group, and pain levels and healing rates were similar. Other complications like swelling, bleeding, and tissue changes also showed no meaningful differences.
These findings suggest that A-PRF may not provide the anticipated benefits for high-risk dental patients, challenging assumptions about regenerative treatments in compromised healing environments.
Key Findings
- A-PRF showed no significant improvement in pain or healing compared to standard care
- No cases of osteoradionecrosis occurred in either treatment group during 120-day follow-up
- Postoperative complications were similar between A-PRF and control groups
- Study included 30 radiation therapy patients with 134 total tooth extractions
- Results challenge the assumed benefits of platelet-rich fibrin in high-risk patients
Methodology
Randomized controlled trial with 30 head and neck cancer survivors requiring tooth extractions. 134 extraction sites randomly assigned to A-PRF treatment or control group, with clinical evaluations at multiple time points over 120 days.
Study Limitations
Study limited to 120-day follow-up period and relatively small sample size. Long-term outcomes beyond 4 months were not assessed, and results may not apply to all radiation therapy protocols or patient populations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
